(PRWEB) December 07, 2012
The US Drug Watchdog has dramatically expanded their initiative focused on helping women recipients of a failed transvaginal mesh, tape, or sling medical product, because they fear there could be thousands of victims. The group says, "We are passionate about making certain victims of a transvaginal mesh, tape, or sling failure get to the highest caliber attorneys-who are all women." Court records indicate, "A transvaginal mesh failure occurs when the mesh fails to bind to a woman's pelvic tissues. As a consequence of this, the body rejects the mesh that has been sewn into it. As a result, the transvaginal mesh may start to poke its way through the vaginal wall and protrude out of the vaginal tissue. This complication is more commonly referred to as "erosion." The US Drug Watchdog is urging any woman, who has had the transvaginal mesh, tape, or sling surgical procedure done, and now has developed severe complications to call them immediately at 866-714-6466. As part of their initiative the US Drug Watchdog is offering to send all US women, who are victims of a transvaginal mesh failure to national caliber attorneys-who are all women. http://USDrugWatchdog.Com
The US Drug Watchdog is indicating symptoms of a transvaginal mesh, tape or sling implant failure may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like a transvaginal mesh, tape, or sling failure. If you have a friend, or loved one who is a recipient of a transvaginal mesh, tape, or sling that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We want to make certain these transvaginal mesh, tape, or sling failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com
C.R. Bard, Inc., (MDL No. 2187); American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10161798.htm.
Copyright©2012 Vocus, Inc.
All rights reserved